Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J Radoux

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Bioinformatics|October 28, 2022
The druggable genome: Twenty years laterChris J Radoux, Francesca Vianello, Jake McGreig, et al.
Journal of Medicinal Chemistry|April 5, 2016
Identifying Interactions that Determine Fragment Binding at Protein HotspotsChris J Radoux, Tjelvar S G Olsson, Will R Pitt, et al.
Journal of Medicinal Chemistry|May 13, 2021
Target-Based Evaluation of "Drug-Like" Properties and Ligand EfficienciesPaul D Leeson, A Patricia Bento, Anna Gaulton, et al.
Journal of Chemical Information and Modeling|January 12, 2022
Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related ProteinsMihaela D Smilova, Peter R Curran, Chris J Radoux, et al.
Journal of Chemical Information and Modeling|March 26, 2020
Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug DesignPeter R Curran, Chris J Radoux, Mihaela D Smilova, et al.
Nature Reviews. Drug Discovery|July 21, 2021
The PROTACtable genomeMelanie Schneider, Chris J Radoux, Andrew Hercules, et al.
Nucleic Acids Research|November 7, 2018
ChEMBL: towards direct deposition of bioassay dataDavid Mendez, Anna Gaulton, A Patrícia Bento, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Bioinformatics|October 28, 2022
The druggable genome: Twenty years laterChris J Radoux, Francesca Vianello, Jake McGreig, et al.
Journal of Medicinal Chemistry|April 5, 2016
Identifying Interactions that Determine Fragment Binding at Protein HotspotsChris J Radoux, Tjelvar S G Olsson, Will R Pitt, et al.
Journal of Medicinal Chemistry|May 13, 2021
Target-Based Evaluation of "Drug-Like" Properties and Ligand EfficienciesPaul D Leeson, A Patricia Bento, Anna Gaulton, et al.
Journal of Chemical Information and Modeling|January 12, 2022
Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related ProteinsMihaela D Smilova, Peter R Curran, Chris J Radoux, et al.
Journal of Chemical Information and Modeling|March 26, 2020
Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug DesignPeter R Curran, Chris J Radoux, Mihaela D Smilova, et al.
Nature Reviews. Drug Discovery|July 21, 2021
The PROTACtable genomeMelanie Schneider, Chris J Radoux, Andrew Hercules, et al.
Nucleic Acids Research|November 7, 2018
ChEMBL: towards direct deposition of bioassay dataDavid Mendez, Anna Gaulton, A Patrícia Bento, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 1